1. Home
  2. PBBK vs NVNO Comparison

PBBK vs NVNO Comparison

Compare PBBK & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBBK
  • NVNO
  • Stock Information
  • Founded
  • PBBK 1919
  • NVNO 1987
  • Country
  • PBBK United States
  • NVNO United States
  • Employees
  • PBBK N/A
  • NVNO N/A
  • Industry
  • PBBK Banks
  • NVNO Medical/Dental Instruments
  • Sector
  • PBBK Finance
  • NVNO Health Care
  • Exchange
  • PBBK Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • PBBK 35.6M
  • NVNO 41.0M
  • IPO Year
  • PBBK N/A
  • NVNO N/A
  • Fundamental
  • Price
  • PBBK $15.39
  • NVNO $2.67
  • Analyst Decision
  • PBBK
  • NVNO
  • Analyst Count
  • PBBK 0
  • NVNO 0
  • Target Price
  • PBBK N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • PBBK 2.7K
  • NVNO 92.3K
  • Earning Date
  • PBBK 05-14-2025
  • NVNO 05-07-2025
  • Dividend Yield
  • PBBK N/A
  • NVNO N/A
  • EPS Growth
  • PBBK N/A
  • NVNO N/A
  • EPS
  • PBBK 0.76
  • NVNO N/A
  • Revenue
  • PBBK $12,444,000.00
  • NVNO N/A
  • Revenue This Year
  • PBBK N/A
  • NVNO N/A
  • Revenue Next Year
  • PBBK N/A
  • NVNO $409.09
  • P/E Ratio
  • PBBK $19.75
  • NVNO N/A
  • Revenue Growth
  • PBBK 1.44
  • NVNO N/A
  • 52 Week Low
  • PBBK $12.10
  • NVNO $2.03
  • 52 Week High
  • PBBK $17.75
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • PBBK 46.60
  • NVNO 54.09
  • Support Level
  • PBBK $14.93
  • NVNO $2.30
  • Resistance Level
  • PBBK $16.60
  • NVNO $2.44
  • Average True Range (ATR)
  • PBBK 0.21
  • NVNO 0.23
  • MACD
  • PBBK -0.03
  • NVNO 0.06
  • Stochastic Oscillator
  • PBBK 65.17
  • NVNO 81.27

About PBBK PB Bankshares Inc.

PB Bankshares Inc follows a community bank model and provides multiple services to individuals and small to midsize businesses. Its business consists of attracting retail and commercial deposits from the general public in its market area and investing those deposits, together with funds generated from operations and borrowings, in commercial real estate loans, commercial and industrial loans, construction, home equity lines of credit and to a lesser extent, one- to four-family residential real estate loans and consumer loans.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: